Thomas MG - Search Results

1

The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease.

Russell AC, Šimurina M, Garcia MT, Novokmet M, Wang Y, Rudan I, Campbell H, Lauc G, Thomas MG, Wang W. Russell AC, et al. Among authors: thomas mg. Glycobiology. 2017 May 1;27(5):501-510. doi: 10.1093/glycob/cwx022. Glycobiology. 2017. PMID: 28334832

2

The impact of dementia development concurrent with Parkinson's disease: a new perspective.

Russell A, Drozdova A, Wang W, Thomas M. Russell A, et al. CNS Neurol Disord Drug Targets. 2014;13(7):1160-8. doi: 10.2174/1871527313666140917122739. CNS Neurol Disord Drug Targets. 2014. PMID: 25230219 Review.

3

Beyond factor analysis: Multidimensionality and the Parkinson's Disease Sleep Scale-Revised.

Pushpanathan ME, Loftus AM, Gasson N, Thomas MG, Timms CF, Olaithe M, Bucks RS. Pushpanathan ME, et al. Among authors: thomas mg. PLoS One. 2018 Feb 12;13(2):e0192394. doi: 10.1371/journal.pone.0192394. eCollection 2018. PLoS One. 2018. PMID: 29432463 Free PMC article.

4

Personality affects aspects of health-related quality of life in Parkinson's disease via psychological coping strategies.

Whitworth SR, Loftus AM, Skinner TC, Gasson N, Barker RA, Bucks RS, Thomas MG. Whitworth SR, et al. Among authors: thomas mg. J Parkinsons Dis. 2013;3(1):45-53. doi: 10.3233/JPD-120149. J Parkinsons Dis. 2013. PMID: 23938310

5

The relationship between sleep and cognition in Parkinson's disease: A meta-analysis.

Pushpanathan ME, Loftus AM, Thomas MG, Gasson N, Bucks RS. Pushpanathan ME, et al. Among authors: thomas mg. Sleep Med Rev. 2016 Apr;26:21-32. doi: 10.1016/j.smrv.2015.04.003. Epub 2015 Apr 25. Sleep Med Rev. 2016. PMID: 26365136 Free article. Review.

6

Bone marrow stromal cells as replacement cells for Parkinson's disease: generation of an anatomical but not functional neuronal phenotype.

Thomas MG, Stone L, Evill L, Ong S, Ziman M, Hool L. Thomas MG, et al. Transl Res. 2011 Feb;157(2):56-63. doi: 10.1016/j.trsl.2010.11.001. Epub 2010 Dec 5. Transl Res. 2011. PMID: 21256457

7

Exercise and Parkinson's: benefits for cognition and quality of life.

Cruise KE, Bucks RS, Loftus AM, Newton RU, Pegoraro R, Thomas MG. Cruise KE, et al. Among authors: thomas mg. Acta Neurol Scand. 2011 Jan;123(1):13-9. doi: 10.1111/j.1600-0404.2010.01338.x. Acta Neurol Scand. 2011. PMID: 20199518 Clinical Trial.

8

Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson's disease.

White RB, Thomas MG. White RB, et al. Among authors: thomas mg. CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):340-9. doi: 10.2174/187152712800792758. CNS Neurol Disord Drug Targets. 2012. PMID: 22483315 Review.

9

Motor Subtype as a Predictor of Future Working Memory Performance in Idiopathic Parkinson's Disease.

Johnson AR, Bucks RS, Kane RT, Thomas MG, Gasson N, Loftus AM. Johnson AR, et al. Among authors: thomas mg. PLoS One. 2016 Mar 25;11(3):e0152534. doi: 10.1371/journal.pone.0152534. eCollection 2016. PLoS One. 2016. PMID: 27015637 Free PMC article.

10

Suitability of the Depression, Anxiety, and Stress Scale in Parkinson's Disease.

Johnson AR, Lawrence BJ, Corti EJ, Booth L, Gasson N, Thomas MG, Loftus AM, Bucks RS. Johnson AR, et al. Among authors: thomas mg. J Parkinsons Dis. 2016 May 27;6(3):609-16. doi: 10.3233/JPD-160842. J Parkinsons Dis. 2016. PMID: 27258699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

653 results

Search Page

Filters